Intuitive Surgical (NASDAQ:ISRG) PT Raised to $518.00

Intuitive Surgical (NASDAQ:ISRG) had its price target upped by BTIG Research from $494.00 to $518.00 in a research note published on Monday morning, Benzinga reports. The brokerage currently has a buy rating on the medical equipment provider’s stock.

Several other research analysts have also issued reports on the stock. Truist Financial increased their target price on shares of Intuitive Surgical from $520.00 to $570.00 and gave the stock a buy rating in a research note on Monday. Evercore ISI upped their price objective on shares of Intuitive Surgical from $410.00 to $475.00 and gave the stock an in-line rating in a report on Tuesday, October 1st. Piper Sandler upped their price objective on shares of Intuitive Surgical from $490.00 to $495.00 and gave the stock an overweight rating in a report on Friday, July 19th. Stifel Nicolaus upped their price objective on shares of Intuitive Surgical from $430.00 to $475.00 and gave the stock a buy rating in a report on Friday, July 19th. Finally, Raymond James upped their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the stock an outperform rating in a report on Monday. Six equities research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to MarketBeat, Intuitive Surgical has a consensus rating of Moderate Buy and a consensus target price of $467.55.

Intuitive Surgical Stock Up 0.6 %

Shares of NASDAQ ISRG opened at $487.61 on Monday. The firm has a market cap of $172.96 billion, a PE ratio of 88.02, a P/E/G ratio of 5.40 and a beta of 1.39. Intuitive Surgical has a 12-month low of $254.85 and a 12-month high of $496.48. The company’s fifty day simple moving average is $481.33 and its 200 day simple moving average is $435.81.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. The business had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. Intuitive Surgical had a net margin of 27.65% and a return on equity of 13.04%. Intuitive Surgical’s revenue was up 14.5% on a year-over-year basis. During the same period in the prior year, the firm earned $1.18 earnings per share. On average, equities analysts predict that Intuitive Surgical will post 5.22 earnings per share for the current year.

Insider Activity at Intuitive Surgical

In related news, Director Amy L. Ladd sold 450 shares of the stock in a transaction dated Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the completion of the transaction, the director now owns 821 shares in the company, valued at approximately $402,519.88. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of the stock in a transaction dated Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total transaction of $641,382.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Amy L. Ladd sold 450 shares of the stock in a transaction dated Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the transaction, the director now owns 821 shares of the company’s stock, valued at $402,519.88. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 53,120 shares of company stock worth $25,528,753. 0.90% of the stock is owned by company insiders.

Hedge Funds Weigh In On Intuitive Surgical

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ISRG. Integrated Advisors Network LLC boosted its position in Intuitive Surgical by 6.3% during the fourth quarter. Integrated Advisors Network LLC now owns 1,598 shares of the medical equipment provider’s stock worth $539,000 after purchasing an additional 95 shares during the period. Centaurus Financial Inc. boosted its position in shares of Intuitive Surgical by 12.2% in the fourth quarter. Centaurus Financial Inc. now owns 2,183 shares of the medical equipment provider’s stock valued at $737,000 after acquiring an additional 238 shares during the period. SageView Advisory Group LLC boosted its position in shares of Intuitive Surgical by 619.1% in the fourth quarter. SageView Advisory Group LLC now owns 4,926 shares of the medical equipment provider’s stock valued at $1,662,000 after acquiring an additional 4,241 shares during the period. HighPoint Advisor Group LLC bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $1,181,000. Finally, Nomura Holdings Inc. bought a new position in shares of Intuitive Surgical in the fourth quarter valued at approximately $3,049,000. Institutional investors own 83.64% of the company’s stock.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.